-
Markeder
-
Aksjer
Sustainable finance2025 Euronext ESG Trends ReportLes merA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indekser
Access the white paperInvesting in the future of Europe with innovative indicesLes merThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETF-er
The European market place for ETFsEuronext ETF EuropeLes merInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Fond
-
Obligasjoner
European Defence BondsGroupe BPCE lists the first bondLes merFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Strukturerte produkter
-
Derivater
Where European Government Bonds Meet the FutureFixed Income derivativesLes merTrade mini bond futures on main European government bonds
-
Råvarer
- Oversikt
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Levering og oppgjør
- Spesifikasjoner og ordninger
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesLes merEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Ressurser
Designed to help students navigate the complexities of financial marketsEuronext Trading gameLes merJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
CRYONIC MEDICAL
Identification
La société a pour objet :
- la conception, l’étude, la fabrication, la commercialisation et la distribution de tout matériel médico-chirurgical ;
- la participation de la société, par tous moyens, dans toutes opérations pouvant se rapporter à son objet par voie de création de sociétés nouvelles, de souscriptions ou d’achat de titres ou droits sociaux, de fusion ou autrement ;
- et généralement toutes opérations quelles qu’elles soient se rattachant directement ou indirectement à l’objet ci-dessus ou à tous objets similaires ou annexes et susceptibles de faciliter le développement de la société.
Operation
Première cession portant sur 2 500 titres Prix cession unitaire : 4 euros
Première cession sur le Marché Libre des actions de la Société CRYONIC MEDICAL pour le compte de Madame Marie GELB.
Date de la première cession : 11 octobre 2004
EUROPE FINANCE ET INDUSTRIE Securities